Guinea-Bissau vs Paraguay: Access to anti-retroviral drugs, male
Guinea-Bissau
62.0%
in 2024
Paraguay
61.0%
in 2024
Guinea-Bissau rank
94th
Paraguay rank
97th
Access to anti-retroviral drugs, male over time
- Guinea-Bissau
- Paraguay
How they compare
Guinea-Bissau currently reports 62.0% against 61.0% in Paraguay, a difference of 1.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Paraguay ahead.
Guinea-Bissau ranks 94th and Paraguay ranks 97th of 141 countries.
Paraguay has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.0% | 6.4% | 4.4% | Paraguay |
| 2010s | 19.4% | 34.0% | 14.6% | Paraguay |
| 2020s | 48.0% | 56.2% | 8.2% | Paraguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Guinea-Bissau or Paraguay?
- Guinea-Bissau, at 62.0% against 61.0% in Paraguay as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Guinea-Bissau and Paraguay?
- 1.0%, with Guinea-Bissau ahead.
- How many years of comparable data are there for Guinea-Bissau and Paraguay?
- 25 years are reported by both, from 2000 to 2024.
- How do Guinea-Bissau and Paraguay rank globally for access to anti-retroviral drugs, male?
- Guinea-Bissau ranks 94th and Paraguay ranks 97th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.